James Warburton

James Warburton is a seasoned professional in medical affairs and global drug development, currently serving as the Vice President and Global Program Head for Oncology at Novartis since July 2009, where responsibilities include leading initiatives in lung and prostate cancer. Previous roles at Novartis encompass Vice President Medical Head for Oncology Solid Tumors in the US and UK Country Medical Director for Oncology, focusing on various solid tumors and haematology. Earlier experience includes serving as the Global Program Clinical Head for ophthalmology and as a Senior Medical Advisor in immunology. Prior to Novartis, James Warburton worked as a Medical Advisor at Wyeth. Educational qualifications include an MFPM from The Faculty of Pharmaceutical Medicine, an MRCP from the Royal College of Physicians, and an MBBS along with a BSc(Hons) in Physiology from Guy's and St. Thomas's Medical School.